Ascendis Pharma (ASND)
(Delayed Data from NSDQ)
$135.40 USD
+2.75 (2.07%)
Updated Jun 27, 2024 04:00 PM ET
After-Market: $135.56 +0.16 (0.12%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Ascendis Pharma A/S [ASND/]
Reports for Purchase
Showing records 301 - 303 ( 303 total )
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
October and Full Year 2016 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
R-D Day Showcases a Deepening Pipeline; Reiterate OUTPERFORM and $34 Price Target
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
TransCon Technology Creates Best-In-Class SR-Prodrugs With Strong Intellectual Property; Initiating Coverage with an OUTPERFORM and $34 Price Target.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L